For the first time we could demonstrate that SOD1 inhibition in glioma cells using the small molecule inhibitor ATN-224 sensitizes GB cells towards conditions of the tumor microenvironment including glucose and oxygen deprivation. This evidence concerns the gene SOD1 and neoplasm.